Provides financial flexibility by reducing near-term debt maturities, deferring principal redemption payment, and reducing near-term cash needs December 31, 2024…
Provides financial flexibility by reducing near-term debt maturities, deferring principal redemption payment, and reducing near-term cash needs December 31, 2024…
Phase 3 trial results published in European Journal of Heart Failure identify key target population for Mesoblast allogeneic cell therapy…